Statement of Jocelyn Frye, President of the National Partnership for Women & Families WASHINGTON, D.C. – April 23, 2024 – Today, the Biden administration published a final rule to support higher pay and better work-family balance for workers by...
What States Stand to Gain From a National Paid Family and Medical Leave Program
by Jessica Mason, Molly Kozlowski | Apr 24, 2024 | Paid Leave
Which states have the most to gain from investments like paid leave? We crunched the numbers in our Paid Leave Means A Stronger Nation fact sheet series – a state-by-state look at the growing need for paid family and medical leave laws.
Lawsuits Seek to Weaken Protections for Abortion Access in Emergencies
by Meera Rajput | Apr 22, 2024 | Reproductive Rights
Enacted by Congress in 1986, EMTALA requires U.S. hospitals that receive Medicare funding to give “necessary stabilizing treatment” to people in emergencies, regardless of their ability to pay or whether or not they have insurance.
Dear Boss: I didn’t know what life was going to throw my way
by Jesse Matton | Apr 18, 2024 | Paid Leave
Shortly after having a little boy, my partner and I got to dive into the scary, competitive, expensive and overwhelming process of finding childcare. Fast forward to now, a year and half later, we have only managed to stay afloat as a family because of the flexibility, support, and policies in place that met me exactly when and where I needed them.
NEWS: How women at one Arizona clinic are grappling with abortion ruling
by Repro Health Watch | Apr 18, 2024 | Repro Health Watch
Leah found out she was five weeks pregnant on the same day that the Arizona Supreme Court upheld an 1864 law banning nearly all abortions in the state.
Black Maternal Health Week 2024: The Legacy of Black Maternal Wisdom
by Jessica Bates | Apr 17, 2024 | Maternal Health
To tell the story of reproductive justice without the long history of the labor of Black women’s bodies is to do a disservice to the reproductive justice movement.
NEWS: What we know about the Arizona abortion ban
by Repro Health Watch | Apr 11, 2024 | Repro Health Watch
Arizona’s highest court upheld an 1864 law that bans nearly all abortions, a decision that could have far-reaching consequences for women’s health care and election-year politics in a critical battleground state.
It’s Tax Season. Who’s Budgeting for Women’s Futures?
by Jessica Mason | Apr 10, 2024 | Congressional Relations
Recent budget proposals by the Biden administration and Republicans in Congress show how the two parties plan to support – or not – women and families.
HHS Must Finalize Updated 504 Regulations
by Marissa Ditkowsky | Apr 8, 2024 | Health Justice
In September 2023, the U.S. Department of Health & Human Services proposed a rule updating disability discrimination regulations under Section 504 of the Rehabilitation Act of 1973 for the first time in almost 40 years.
What Does the Jobs Report – and My Grandmother’s Cookbook – Tell Us About the Care Economy? | #JobsDay April 2024
by Katherine Gallagher Robbins | Apr 5, 2024 | Fair Pay
For Care Workers Recognition Month, we look at how caregiving jobs are faring in today’s economy – and why care work is personal for so many people.
NEWS: Florida court allows 6-week abortion ban, but voters will get to weigh in
by Repro Health Watch | Apr 4, 2024 | Repro Health Watch
The Florida Supreme Court overturned decades of legal precedent on Monday in ruling that the State Constitution’s privacy protections do not extend to abortion, effectively allowing Florida to ban the procedure after six weeks of pregnancy.
Bridging the Divide: How Businesses are Investing in Equal Pay and Gender Equity
by Jesse Matton | Mar 29, 2024 | Fair Pay
Businesses play a key role in reducing the gender wage gap.
NEWS: Supreme Court skeptical of challenge to mifepristone
by Repro Health Watch | Mar 28, 2024 | Repro Health Watch
In the first abortion-related case before the Supreme Court since its 2022 decision to overturn Roe v. Wade, a majority of the justices appeared to express skepticism that a coalition of anti-abortion doctors had the right to challenge the Food and Drug Administration’s 2016 and 2021 decisions to expand access to mifepristone, a drug used for medication abortion.